PET Imaging of HSV1-tk Mutants with Acquired Specificity Toward Pyrimidine- and Acycloguanosine-based Radiotracers

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2009 Mar 5

PMID 19259663

Citations 9

Authors

Yury Likar

Konstantin Dobrenkov

Malgorzata Olszewska

Larissa Shenker

Shangde Cai

Hedvig Hricak

Vladimir Ponomarev

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to create an alternative mutant of the herpes simplex virus type 1 thymidine kinase (HSV1-tk) reporter gene with reduced phosphorylation capacity for acycloguanosine derivatives, but not pyrimidine-based compounds that will allow for successful PET imaging.

Methods: A new mutant of HSV1-tk reporter gene, suitable for PET imaging using pyrimidine-based radiotracers, was developed. The HSV1-tk mutant contains an arginine-to-glutamine substitution at position 176 (HSV1-R176Qtk) of the nucleoside binding region of the enzyme.

Results: The mutant-gene product showed favorable enzymatic characteristics toward pyrimidine-based nucleosides, while exhibiting reduced activity with acycloguanosine derivatives. In order to enhance HSV1-R176Qtk reporter activity with pyrimidine-based radiotracers, we introduced the R176Q substitution into the more active HSV1-sr39tk mutant. U87 human glioma cells transduced with the HSV1-R176Qsr39tk double mutant reporter gene showed high (3)H-FEAU pyrimidine nucleoside and low (3)H-penciclovir acycloguanosine analog uptake in vitro. PET imaging also demonstrated high (18)F-FEAU and low (18)F-FHBG accumulation in HSV1-R176Qsr39tk+ xenografts. The feasibility of imaging two independent nucleoside-specific HSV1-tk mutants in the same animal with PET was demonstrated. Two opposite xenografts expressing the HSV1-R176Qsr39tk reporter gene and the previously described acycloguanosine-specific mutant of HSV1-tk, HSV1-A167Ysr39tk reporter gene, were imaged using a short-lived pyrimidine-based (18)F-FEAU and an acycloguanosine-based (18)F-FHBG radiotracer, respectively, administered on 2 consecutive days.

Conclusion: We conclude that in combination with acycloguanosine-specific HSV1-A167Ysr39tk reporter gene, a HSV1-tk mutant containing the R176Q substitution could be used for PET imaging of two different cell populations or concurrent molecular biological processes in the same living subject.

Citing Articles

Applications of nuclear-based imaging in gene and cell therapy: probe considerations.

Volpe A, Pillarsetty N, Lewis J, Ponomarev V Mol Ther Oncolytics. 2021; 20:447-458.

PMID: 33718593 PMC: 7907215. DOI: 10.1016/j.omto.2021.01.017.

How Non-invasive Cell Tracking Supports the Development and Translation of Cancer Immunotherapies.

Iafrate M, Fruhwirth G Front Physiol. 2020; 11:154.

PMID: 32327996 PMC: 7152671. DOI: 10.3389/fphys.2020.00154.

Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.

Ashmore-Harris C, Iafrate M, Saleem A, Fruhwirth G Mol Ther. 2020; 28(6):1392-1416.

PMID: 32243834 PMC: 7264441. DOI: 10.1016/j.ymthe.2020.03.016.

Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade.

Serganova I, Moroz E, Cohen I, Moroz M, Mane M, Zurita J Mol Ther Oncolytics. 2017; 4:41-54.

PMID: 28345023 PMC: 5363727. DOI: 10.1016/j.omto.2016.11.005.

Redesigning human 2'-deoxycytidine kinase enantioselectivity for L-nucleoside analogues as reporters in positron emission tomography.

Muthu P, Chen H, Lutz S ACS Chem Biol. 2014; 9(10):2326-33.

PMID: 25079348 PMC: 4201336. DOI: 10.1021/cb500463f.

References

Mangner T, Klecker R, Anderson L, Shields A . Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU. Nucl Med Biol. 2003; 30(3):215-24. DOI: 10.1016/s0969-8051(02)00445-6. View

Doubrovin M, Ponomarev V, Beresten T, Balatoni J, Bornmann W, Finn R . Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci U S A. 2001; 98(16):9300-5. PMC: 55415. DOI: 10.1073/pnas.161091198. View

Deng W, Yang W, Lai W, Liu R, Hwang J, Yang D . Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir. Eur J Nucl Med Mol Imaging. 2003; 31(1):99-109. DOI: 10.1007/s00259-003-1269-z. View

Gambhir S, Bauer E, Black M, Liang Q, Kokoris M, Barrio J . A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A. 2000; 97(6):2785-90. PMC: 16007. DOI: 10.1073/pnas.97.6.2785. View

Alauddin M, Shahinian A, Kundu R, Gordon E, Conti P . Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol. 1999; 26(4):371-6. DOI: 10.1016/s0969-8051(98)00116-4. View

Choi S, Zhuang Z, Chacko A, Acton P, Tjuvajev-Gelovani J, Doubrovin M . SPECT imaging of herpes simplex virus type1 thymidine kinase gene expression by [(123)I]FIAU(1). Acad Radiol. 2005; 12(7):798-805. DOI: 10.1016/j.acra.2005.04.010. View

Ponomarev V, Doubrovin M, Serganova I, Beresten T, Vider J, Shavrin A . Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging. Neoplasia. 2003; 5(3):245-54. PMC: 1502405. DOI: 10.1016/S1476-5586(03)80056-8. View

Black M, Kokoris M, Sabo P . Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. Cancer Res. 2001; 61(7):3022-6. View

Balatoni J, Doubrovin M, Ageyeva L, Pillarsetty N, Finn R, Gelovani J . Imaging herpes viral thymidine kinase-1 reporter gene expression with a new 18F-labeled probe: 2'-fluoro-2'-deoxy-5-[18F]fluoroethyl-1-beta-d-arabinofuranosyl uracil. Nucl Med Biol. 2005; 32(8):811-9. DOI: 10.1016/j.nucmedbio.2005.07.007. View

10.

Min J, Iyer M, Gambhir S . Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection. Eur J Nucl Med Mol Imaging. 2003; 30(11):1547-60. DOI: 10.1007/s00259-003-1238-6. View

11.

Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo H, Ivanova A . Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol. 2003; 21(4):405-13. DOI: 10.1038/nbt805. View

12.

Likar Y, Dobrenkov K, Olszewska M, Vider E, Shenker L, Cai S . A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs. J Nucl Med. 2008; 49(5):713-20. PMC: 2735464. DOI: 10.2967/jnumed.107.046425. View

13.

Alauddin M, Shahinian A, Park R, Tohme M, Fissekis J, Conti P . In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging. 2007; 34(6):822-9. DOI: 10.1007/s00259-006-0305-1. View

14.

Ponomarev V, Doubrovin M, Lyddane C, Beresten T, Balatoni J, Bornman W . Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia. 2002; 3(6):480-8. PMC: 1506564. DOI: 10.1038/sj.neo.7900204. View

15.

Kuonen O, Folkers G, Pilger B, Scapozza L . Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase. Eur J Biochem. 1998; 255(2):472-81. DOI: 10.1046/j.1432-1327.1998.2550472.x. View

16.

Yaghoubi S, Gambhir S . PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG. Nat Protoc. 2007; 1(6):3069-75. DOI: 10.1038/nprot.2006.459. View

17.

Alauddin M, Shahinian A, Gordon E, Conti P . Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol Imaging. 2004; 3(2):76-84. DOI: 10.1162/15353500200403160. View

18.

Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L . Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 2001; 358(9283):727-9. DOI: 10.1016/s0140-6736(01)05904-9. View

19.

Soghomonyan S, Hajitou A, Rangel R, Trepel M, Pasqualini R, Arap W . Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU. Nat Protoc. 2007; 2(2):416-23. DOI: 10.1038/nprot.2007.49. View

20.

Alauddin M, Conti P . Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol. 1998; 25(3):175-80. DOI: 10.1016/s0969-8051(97)00160-1. View